CI Relative Valuation - Cigna Corp

Watchlist Manager

Watchlist

Price: 262.44 USD -2.68% Market Closed

Market Cap: $70.1B

Relative Value

The Relative Value of one CI stock under the Base Case scenario is 609.02 USD. Compared to the current market price of 262.44 USD, Cigna Corp is Undervalued by 57%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

CI Relative Value

Base Case

Undervaluation 57%

Relative Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

P/B

Forward Multiples

			Market Cap	P/S	P/E	P/B
US		Cigna Corp NYSE:CI	69.1B USD	0.3	11.6	1.7
US		CVS Health Corp NYSE:CVS	97B USD	0.2	54.9	1.3
US	C	Cigna Group XMUN:CGN	68.2B EUR	0.3	13.3	1.9
DE		Fresenius SE & Co KGaA XETRA:FRE	27.3B EUR	1.2	21.6	1.5
DE		Fresenius Medical Care AG XMUN:FME	22.9B EUR	1.2	23.4	1.7
US		Laboratory Corporation of America Holdings NYSE:LH	22.1B USD	1.6	25.2	2.6
US		Quest Diagnostics Inc NYSE:DGX	22.1B USD	2	22.4	3.1
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.1B EUR	0.6	11.3	0.8
US		Guardant Health Inc NASDAQ:GH	11.8B USD	12	-28.4	-119
US		DaVita Inc NYSE:DVA	10.4B USD	0.8	13.9	-16
US		Brightspring Health Services Inc NASDAQ:BTSG	7.9B USD	0	0	0

				Revenue Growth	P/S to Growth
US		Cigna Corp NYSE:CI	Average P/S: 2 0.3	6%	0
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.2	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	3%	0.2
US		Guardant Health Inc NASDAQ:GH	12	30%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	16%	N/A

				Earnings Growth	PEG
US		Cigna Corp NYSE:CI	Average P/E: 22 11.6	19%	0.6
US		CVS Health Corp NYSE:CVS	54.9	90%	0.6
US	C	Cigna Group XMUN:CGN	13.3	19%	0.7
DE		Fresenius SE & Co KGaA XETRA:FRE	21.6	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	23.4	16%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	25.2	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	22.4	12%	1.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.3	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -28.4	N/A	N/A
US		DaVita Inc NYSE:DVA	13.9	21%	0.7
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	27%	N/A


US		Cigna Corp NYSE:CI	Average P/B: 1.8 1.7
US		CVS Health Corp NYSE:CVS	1.3
US	C	Cigna Group XMUN:CGN	1.9
DE		Fresenius SE & Co KGaA XETRA:FRE	1.5
DE		Fresenius Medical Care AG XMUN:FME	1.7
US		Laboratory Corporation of America Holdings NYSE:LH	2.6
US		Quest Diagnostics Inc NYSE:DGX	3.1
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -119
US		DaVita Inc NYSE:DVA	Negative Multiple: -16
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available

Cigna Corp
NYSE:CI

Relative Value

Valuation Multiples

Multiples Across Competitors

CI Competitors Multiples
Cigna Corp Competitors

See Also

Company

Help

Tools

Stocks

Cigna Corp NYSE:CI

Relative Value

Valuation Multiples

Multiples Across Competitors

CI Competitors Multiples Cigna Corp Competitors

See Also

Company

Help

Tools

Stocks

Cigna Corp
NYSE:CI

CI Competitors Multiples
Cigna Corp Competitors